KAITLIN WALLS: Open Payments
NPI 1457884231 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 36 payments from 11 companies in 2025. Trend: 2023 $292 · 2024 $413 · 2025 $767
Food & beverage: $668Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $167 |
| Madrigal Pharmaceuticals | 9 | $161 |
| Janssen Biotech, Inc. | 4 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| PFIZER INC. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Braintree Laboratories, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
Products named: REZDIFFRA, TREMFYA, LINZESS, RINVOQ, XIFAXAN, VELSIPITY, VOQUEZNA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
